BioFab Project - Program Management Services
EMD Pharmaceuticals, Inc., (Merck KGaA)

Aker Kvaerner has secured a contract for preliminary design of a new large-scale multi-product Mammalian Cell Culture facility for EMD Pharmaceuticals Inc., of Durham, N.C., an affiliate of Merck KGaA of Darmstadt, Germany.

KEMWorks has been contracted to provide Program Management for the engineering, procurement and validation for Aker Kvaerner. KEMWorks provided program management services for the conceptual design competition and presentation to the client as well as follow-up through selection of the successful team. KEMWorks will provide the overall program management throughout the project through successful OQ completion including project management, planning, scheduling, cost and change management.

The BioFab Project will commence immediately. The state of the art EMD BioPharmaceutical facility will include laboratories, offices, warehouse and the cGMP Mammalian Cell Culture plant. Implementation of the BioFab project will be in two phases: Phase I - the preliminary design - will begin immediately and Phase II is scheduled to begin in mid-2003, after Merck KGaA has made a final determination of where the facility will be located. The project is planned to be complete by mid-2006.